BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 14673154)

  • 1. Mdm2 regulates p53 independently of p19(ARF) in homeostatic tissues.
    O'Leary KA; Mendrysa SM; Vaccaro A; Perry ME
    Mol Cell Biol; 2004 Jan; 24(1):186-91. PubMed ID: 14673154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
    Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
    Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sumoylation induced by the Arf tumor suppressor: a p53-independent function.
    Tago K; Chiocca S; Sherr CJ
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7689-94. PubMed ID: 15897463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53-independent apoptosis is induced by the p19ARF tumor suppressor.
    Tsuji K; Mizumoto K; Sudo H; Kouyama K; Ogata E; Matsuoka M
    Biochem Biophys Res Commun; 2002 Jul; 295(3):621-9. PubMed ID: 12099684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2.
    Tao W; Levine AJ
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6937-41. PubMed ID: 10359817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.
    Kamijo T; Weber JD; Zambetti G; Zindy F; Roussel MF; Sherr CJ
    Proc Natl Acad Sci U S A; 1998 Jul; 95(14):8292-7. PubMed ID: 9653180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing.
    Sugimoto M; Kuo ML; Roussel MF; Sherr CJ
    Mol Cell; 2003 Feb; 11(2):415-24. PubMed ID: 12620229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARF function does not require p53 stabilization or Mdm2 relocalization.
    Korgaonkar C; Zhao L; Modestou M; Quelle DE
    Mol Cell Biol; 2002 Jan; 22(1):196-206. PubMed ID: 11739734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic ras activates the ARF-p53 pathway to suppress epithelial cell transformation.
    Lin AW; Lowe SW
    Proc Natl Acad Sci U S A; 2001 Apr; 98(9):5025-30. PubMed ID: 11309506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
    Eischen CM; Weber JD; Roussel MF; Sherr CJ; Cleveland JL
    Genes Dev; 1999 Oct; 13(20):2658-69. PubMed ID: 10541552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the molecular basis of Arf and Hdm2 interactions.
    Bothner B; Lewis WS; DiGiammarino EL; Weber JD; Bothner SJ; Kriwacki RW
    J Mol Biol; 2001 Nov; 314(2):263-77. PubMed ID: 11718560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
    Eischen CM; Alt JR; Wang P
    Oncogene; 2004 Nov; 23(55):8931-40. PubMed ID: 15467748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.
    Stott FJ; Bates S; James MC; McConnell BB; Starborg M; Brookes S; Palmero I; Ryan K; Hara E; Vousden KH; Peters G
    EMBO J; 1998 Sep; 17(17):5001-14. PubMed ID: 9724636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nucleophosmin (B23) targets ARF to nucleoli and inhibits its function.
    Korgaonkar C; Hagen J; Tompkins V; Frazier AA; Allamargot C; Quelle FW; Quelle DE
    Mol Cell Biol; 2005 Feb; 25(4):1258-71. PubMed ID: 15684379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
    Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
    Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors.
    Eymin B; Gazzeri S; Brambilla C; Brambilla E
    Oncogene; 2002 Apr; 21(17):2750-61. PubMed ID: 11965548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53- and Mdm2-independent repression of NF-kappa B transactivation by the ARF tumor suppressor.
    Rocha S; Campbell KJ; Perkins ND
    Mol Cell; 2003 Jul; 12(1):15-25. PubMed ID: 12887889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arf induces p53-dependent and -independent antiproliferative genes.
    Kuo ML; Duncavage EJ; Mathew R; den Besten W; Pei D; Naeve D; Yamamoto T; Cheng C; Sherr CJ; Roussel MF
    Cancer Res; 2003 Mar; 63(5):1046-53. PubMed ID: 12615721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.